Tag: clinical trials
-
Clinical Trial Testing West Nile Vaccine
7 May 2015. A vaccine for West Nile virus, a seasonal infection spread by mosquitoes, is being tested for safety in an early stage clinical trial. The vaccine, code-named HydroVax-001, is being developed in the lab of microbiologist Mark Slifka at Oregon Health and Science University in Beaverton and commercialized by Najit Technologies Inc., a…
-
Trial Underway Testing RNA Therapy for Rare Liver Disorder
5 May 2015. An early-stage clinical trial is testing a therapy derived from genetic material to treat alpha-1 antitrypsin deficiency, a rare inherited disease affecting the liver and lungs. The therapy, code-named ARC-AAT, is developed by Arrowhead Research Corporation, a biopharmaceutical company in Pasadena, California. Alpha-1 antitrypsin deficiency, or AATD, is caused by a mutation…
-
Stem Cells Treat Vision Disorders in Animal Tests
4 May 2015. Tests with lab rats of a therapy for degenerating retinas in the eyes, show the treatments derived from human embryonic stem cells can restore visual functions. Results of the treatments, developed by Cell Cure Neurosciences Ltd., are scheduled to be reported today by a research team from Oregon Health and Science University…
-
Heart Drug Developer Raises $46M in Venture Funds
1 May 2015. MyoKardia Inc., a developer of therapies for inherited heart diseases, raised $46 million in its second venture funding round. Taking part in the financing for the South San Francisco, California company are the drug company Sanofi that already holds an equity stake in MyoKardia, as well as venture capital firms Casdin Capital,…
-
Robotic Exoskeleton Developed for Upper-Body Rehab
1 May 2015. A robotic device that helps recover upper-body functions for people with neurological or spinal injuries is being developed by engineers at University of Texas in Austin. Developers of the exoskeleton, called Harmony, plan clinical trials of the device later in 2015. Harmony is a project of UT-Austin’s Rehabilitation and Neuromuscular Robotics Laboratory…
-
Aduro Biotech Raises $108 million in IPO
15 April 2015. Aduro Biotech Inc., a developer of immunotherapies to treat cancer, issued its initial public stock offering today that expects to net the company some $108 million, after issuing 7 million shares priced at $17.00. The Berkeley, California enterprise trades on the Nasdaq exchange under symbol ADRO. As of the Nasdaq closing bell…
-
Trial Shows Multiple Sclerosis Drug Improves Optic Nerves
15 April 2015. A clinical trial testing a new therapy for multiple sclerosis shows the drug improves the performance of optic nerves in patients with acute optic neuritis, a condition highly associated with multiple sclerosis. Researchers from the biotechnology company Biogen present their findings next week at the annual meeting of American Academy of Neurology…
-
Trial Testing App to Manage Diabetes, Foot Ulcers
14 April 2015. A clinical trial is getting under way testing a smartphone app to help people with diabetes manage their condition, and in particular assess chronic foot ulcers associated with diabetes. The application is the work of an information technology and biomedical engineering team at Worcester Polytechnic Institute in Massachusetts, that described the system…
-
Janssen Licensing DNA Technology for Hep B Vaccine
13 April 2015. Janssen Pharmaceuticals, a division of Johnson & Johnson, is licensing an electronic DNA drug delivery technology from Ichor Medical Systems for vaccines to treat hepatitis B. Ichor, based in San Diego, expects to gain as much as $85 million in the deal. Hepatitis B is a liver infection caused by a virus…
-
Trial Testing Mobile Apps for Mood Management
9 April 2015. A lab at Northwestern University medical school developed a collection of mobile apps for helping people cope with feelings of depression and anxiety, and is testing the apps as personalized interventions in a clinical trial. The study is led by David Mohr, director of Northwestern’s Center for Behavioral Intervention Technologies, who is…